Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis

. 2009 Aug ; 28 (8) : 899-905. [epub] 20090324

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid19308651

Interleukin-10 (IL-10) is an immunoregulatory cytokine, usually considered to mediate the downregulation of the inflammatory response in rheumatoid arthritis (RA). Some effects of IL-10 are not anti-inflammatory; for example, the activation of B cells to promote autoantibody production. Allelic polymorphisms located in the promoter region of the IL-10 gene may contribute to the regulation of autoantibodies production. To examine the putative association between the -1082 G/A polymorphism in the promoter region of the IL-10 gene and the susceptibility to disease onset and severity of RA, a total of 144 patients with RA diagnosed according to the revised criteria of the American College of Rheumatology for RA were consecutively recruited into the study. Radiographic progression of RA was scored according to the Sharp/van der Heijde method. Serum levels of rheumatoid factors (RFs) were measured by enzyme-linked immunosorbent assay. Polymerase chain reaction amplification was used for the analysis of the promoter polymorphism of the IL-10 gene. We observed significant differences in genotype distribution of the -1082 G/A polymorphism between IgM RF, IgA RF, and IgG RF positive/negative subgroups of RA patients, with higher prevalence of the GG genotype within IgM RF (Pg = 0.006), IgA RF (Pg = 0.05), and IgG RF (Pg = 0.007) negative RA patients. Results obtained in this study provide the evidence of an association between the -1082 G/A polymorphism in the IL-10 gene promoter and the production of RFs in RA patients.

Zobrazit více v PubMed

Scand J Immunol. 1996 Dec;44(6):607-14 PubMed

Clin Calcium. 2007 Apr;17(4):517-25 PubMed

Lancet. 1997 Jan 18;349(9046):170-3 PubMed

Eur J Immunogenet. 1997 Feb;24(1):1-8 PubMed

J Clin Invest. 1995 Nov;96(5):2304-10 PubMed

Arthritis Rheum. 1985 Dec;28(12):1326-35 PubMed

Clin Immunol Immunopathol. 1976 Nov;6(3):414-30 PubMed

Immunogenetics. 1995;42(5):444-5 PubMed

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9465-70 PubMed

Immunogenetics. 1997;46(2):120-8 PubMed

Immunology. 1997 Jun;91(2):252-9 PubMed

Arthritis Rheum. 1995 Dec;38(12):1771-6 PubMed

Scand J Rheumatol. 1998;27(2):142-5 PubMed

Immunol Today. 1997 Jun;18(6):277-80 PubMed

J Exp Med. 1994 Dec 1;180(6):2371-6 PubMed

Genes Immun. 2003 Mar;4(2):117-21 PubMed

Cytokine. 1998 May;10(5):361-9 PubMed

J Leukoc Biol. 1997 Apr;61(4):389-96 PubMed

Eur J Immunol. 1994 Nov;24(11):2699-705 PubMed

Immunogenetics. 1996;45(1):82-3 PubMed

Curr Opin Rheumatol. 1998 May;10(3):187-200 PubMed

Immunol Lett. 1999 Sep 1;69(3):301-6 PubMed

Clin Exp Immunol. 1998 Jun;112(3):516-27 PubMed

Scand J Rheumatol. 1997;26(6):448-55 PubMed

Arthritis Rheum. 1995 Jan;38(1):96-104 PubMed

Arthritis Rheum. 1997 Feb;40(2):249-60 PubMed

Br J Rheumatol. 1998 Sep;37(9):988-91 PubMed

Tissue Antigens. 1997 Sep;50(3):303-7 PubMed

J Rheumatol Suppl. 1996 Mar;44:31-3 PubMed

Arthritis Rheum. 1988 Mar;31(3):315-24 PubMed

Clin Rheumatol. 2007 Feb;26(2):201-4 PubMed

Ann Rheum Dis. 1999 Feb;58(2):85-9 PubMed

Rheumatology (Oxford). 1999 Apr;38(4):293-7 PubMed

Clin Exp Immunol. 1995 Mar;99(3):331-7 PubMed

Arthritis Rheum. 1999 Jun;42(6):1101-8 PubMed

Adv Immunol. 1994;56:389-466 PubMed

Rheumatology (Oxford). 2000 Nov;39(11):1180-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...